Jaguar Health Declares Special One-Time Stock Dividend

Jaguar Health, Inc. has announced a special one-time stock dividend aimed at providing dilution protection for its shareholders as the company explores debt restructuring options. As of the record date on March 2, 2026, holders of Jaguar Common Stock and certain warrants will receive Series O Convertible Preferred Stock. The conversion into Common Stock will occur by December 31, 2026, based on market prices.

CEO Lisa Conte emphasized the dividend as a reward for shareholders and a strategic move to manage debt. The company continues to focus on its global development program for crofelemer, targeting rare pediatric intestinal conditions. A significant step includes pursuing Breakthrough Therapy designation for crofelemer in treating microvillus inclusion disease.

The special stock dividend will be distributed on March 4, 2026. Future dividends remain at the discretion of the board.